The special two-hour flight will fly the path of totality during its peak shadow casting, led by former NASA astronaut and JSX pilot Bill Gregory. Photo via JSX

With Texas set to be the prime location for the Great North American Solar Eclipse, airlines are lining up to offer the best vantage point and that includes JSX: The private carrier is offering a once-in-a-lifetime in-flight experience to 12 people, to join a specialty flight from Dallas on Monday, April 8.

This special two-hour flight will fly the path of totality during its peak shadow casting, led by former NASA astronaut and JSX pilot Bill Gregory. Those onboard will receive eclipse viewing glasses for safe solar viewing, themed Solar Eclipse cocktails, and complimentary sun protection.

Flight 4824 will depart on April 8 from JSX’s dedicated hangar at Dallas-Love Field at 1 pm. Every occupant will get their own dedicated window seat for the best chance of viewing the total solar eclipse as the plane travels within the path of totality, circling Dallas, and landing back at the hangar by 3 pm.

Space enthusiasts looking for a unique vantage point from 30,000 feet up can enter the sweepstakes online now until March 14, for a free chance to view the solar phenomenon with a guest.

In addition to the sweepstakes, the hop-on air carrier is partnering with Dallas Love Field’s Frontiers of Flight Museum to identify two children in the local Texas community with an interest in STEM to experience the rare spectacle with a guardian.

Previously serving as NASA’s Space Shuttle Endeavour pilot and having completed 262 orbits and traveling nearly seven million miles in space, JSX’s Bill Gregory will navigate the solar eclipse with expert commentary throughout the flight. Before joining the JSX team, Bill also served as a former U.S. Air Force Lieutenant Colonel and has received numerous accolades for his professional achievements including the NASA Space Flight Medal, Defense Superior Service Medal, Meritorious Service Medal, and more.

“With Dallas taking claim as the biggest city in the path of totality, we are thrilled to make this ultra premium and rare viewing opportunity a reality via JSX,” says CEO Alex Wilcox. “We’re committed to prioritizing safe, simple, joy-filled flights for all and are ecstatic to be able to provide travelers with the ultimate JSX experience in tandem with this once-in-a-lifetime celestial event.”

Other airlines offering special eclipse flights include Southwest Airlines and Delta.

JSX is the flight experience that offers convenience at an accessible price point, from checking in at a dedicated hangar 20 minutes prior to departure to flying on a sleek 30-seat jet, to business class legroom, frictionless security, free high speed Starlink Wi-Fi, and in-seat power.

------

This article originally ran on CultureMap.

Behold the future JSX Aura Aero Era 19-seat hybrid-electric aircraft. Rendering courtesy of JSX

Texas company lines up hundreds electric-hybrid planes for takeoff

flying green

Hop-on jet service JSX is soaring into a more eco-friendly future with plans to acquire more than 300 hybrid-electric airplanes.

The Dallas-based air carrier revealed in a release that they'll add up to 332 small hybrid planes in 2028, allowing them to connect to smaller, underserved communities around the country.

"Following the Biden Administration’s call last week for the aviation industry to cut carbon emissions ... JSX expects to take delivery of its first hybrid-electric aircraft in 2028, shepherding the next chapter of regional aviation as the first in its category to adopt this impactful cutting-edge renewable energy technology," JSX says in the release. "While commercial airlines can serve just 480 airports in the United States, JSX’s small community-friendly Part 135 and Part 380 Public Charter operations, combined with the exceptional performance capabilities of these hybrid-electric airplanes, enables service opportunities to thousands of federally funded airports otherwise inaccessible to people who can’t own or charter an entire aircraft."

The new cutting-edge airplanes will come from manufacturers Electra, Aura Aero, and Heart Aerospace and will include:

  • up to 82 Electra eSTOL 9-seat aircraft (32 firm orders and 50 options)
  • up to 150 Aura Aero Era 19-seat planes (50 firm orders and 100 options)
  • up to 100 Heart Aerospace ES-30 30-seat planes (50 firm orders and 50 options)

JSX currently operates about 50 semi-private planes configured with 30 seats, from private terminals in major cities including Dallas (Love Field) and Houston (Hobby Airport), and in "leisure" markets such as Destin, Florida and the Bahamas. The company recently shifted part of its operational focus to small markets (such as Midland-Odessa).

JSX promises a "no crowds, no lines, and no fuss" travel experience, allowing customers to check in and "hop on" just 20 minutes before departure. The carrier recently came under fire from federal regulators and major commercial airlines for its looser security regulations that more closely resemble those of charter providers than those of domestic airlines.

JSX is now doubling down on its pledge to service underserved cities, declaring in the release, "JSX has mastered the trifecta of marketing, selling, and operating attainable by-the-seat public charter air service to numerous small communities that have no other regular air service."


The future Heart Aerospace ES-30 30-seat hybrid-electric aircraft in JSX livery. Rendering courtesy of JSX


The new smaller, electric-hybrid aircraft will allow JSX to "dramatically lower the cost of its service and open new flight options at over 2,000 U.S. airports," they say, "stimulating local economies and empowering regional mobility and connectivity for communities devoid of regular air service today."

They point specifically to Del Rio, Texas, which has lost all commercial air service since the pandemic, they say, as an example of a small city that now can be reconnected to major cities in a cost-effective, sustainable way.

"The favorable operating economics of the Aura Aero Era, Heart ES-30, and Electra eSTOL can create thousands of new and expanded air travel options across the United States without the need for government subsidy," the company says.

In a statement, JSX CEO and cofounder Alex Wilcox adds, "As the network airlines order ever-larger aircraft it is inevitable that more and more small markets will be abandoned. Electra, Aura Aero, and Heart Aerospace are visionary organizations that share in JSX’s commitment to serving smaller communities, working together with us to weave sustainable regional air travel back into the fabric of American commerce and freedom of movement.”

———

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

4 Houston health tech startups advancing medical innovation

meet the finalists

Houston has been driving medical innovation for decades. And thanks to leading hospitals, cutting-edge research and breakthrough technologies, the region’s healthcare ecosystem continues to improve how patients are diagnosed, treated and cared for.

The Health Tech Business category in our 2025 Houston Innovation Awards will honor an innovative startup within the health and medical technology sectors.

Four forward-thinking businesses have been named finalists for the 2026 award. This year's finalists, selected by our esteemed panel of judges, range from a startup developing miniaturized medical technologies for space to a company using AI to help develop cancer treatment plans.

Read more about these businesses, their innovative founders, and how they're shaping the future of health care below.. The 2026 winners will be announced on InnovationMap.com in mid-November.

Bairitone Health

Bairitone Health is bringing anatomy imaging for sleep apnea to the home environment. The company's platform maps users' anatomy during natural sleep using a facial patch to determine the root cause of airway obstruction. It then offers effective therapies for each patient.

The company was founded in 2022 in the Texas Medical Center's Biodesign program by CEO Meagan Pitcher, CTO Onur Kilic and chief medical officer Britt Cross. It was a member of Activate Houston's inaugural cohort and has participated in numerous accelerators and incubators. The company raised an oversubscribed seed round for $2.4 million earlier this year and received Breakthrough Device Designation from the Food and Drug Administration in April.

InformAI Inc.

InformAI Inc. develops fit-to-purpose AI solutions for the clinical setting. Its RadOncAI product recently received FDA 510(k) clearance. The product uses AI to create a first-pass radiation therapy dose plan for complex head and neck cancers in an effort to eliminate bottlenecks in radiation planning and ultimately cancer treatment. The company has also developed AI products for sinus disease detection and 3D organ reconstruction.

CEO Jim Havelka founded the company in 2017. It is participating in the Mayo Clinic Accelerate Platform. It has raised about $4 million in seed funding and has received numerous non-dilutive grants from the National Science Foundation, the National Institutes of Health and the Cancer Prevention and Research Institute of Texas. The company shared in its application that it plans to launch a Series A fundraising round and submit an FDA 510K application for its organ reconstruction product, Voluquant, by the end of 2026.

Prana Surgical

Prana Surgical is developing a minimally invasive surgical platform for small, hard-to-reach lung nodules that may be cancerous. The company's Prana System cleared U.S. Food and Drug Administration (FDA) approval earlier this year.

Prana Surgical was originally founded as Prana Thoracic in 2022. It has participated in numerous accelerators, including the Texas Medical Center Innovation Accelerator in 2023 and the IGNITE Health accelerator in 2022. It raised $6 million in Series A funding rounds in 2023 and 2024 , with a Series B currently ongoing. The company said in its application that it is currently moving into the next stage of clinical validation and revenue generation in the U.S., in addition to preparing its manufacturing and commercial infrastructure for broader use.

Skybound MedTech

Skybound MedTech develops technologies that aim to address the health risks of long-duration spaceflight. Its compact, miniaturized medical technologies can deliver complex therapies without a physician.

CEO Matthew Kuhn, who previously founded Taurus Vascular, founded Skybound last year. The company emerged from stealth in January after raising a $1.25 million Series A round. It plans to advance its lead dual-use platform into critical preclinical validation in November, the company shared in its application. It is currently raising a $25 million Series A round and is pursuing federal research partnerships with DARPA and ARPA-H.

Generation Park lands new facility to scale xeno-organ production

Organ innovation

Maryland-based United Therapeutics Corp. has opened a new 77,448-square-foot facility to manufacture xeno-organs in Northeast Houston’s growing biotech hub, Generation Park.

The new Houston location is United Therapeutics’ third Designated Pathogen-Free (DPF) site, named for transplant pioneers Dr. Bartley P. Griffith and Dr. Robert A. Montgomery. The company says the new facility will enable it to scale commercial production of its xeno-organs once they receive regulatory approval.

An existing DPF facility in Virginia is supporting clinical trials for the xeno-organs, and a third site in Minnesota will also focus on commercialization with the Houston site, according to the company.

Xeno-organs are organs taken from a non-human animal source and transplanted, implanted or infused into a human recipient.

Currently, United Therapeutics is advancing clinical trials to support a Biologics License Application with the U.S. Food and Drug Administration for its investigational-stage xenotransplantation, UKidney, UThymoKidney and UHeart products. The products all involve working with the genes from humans and pigs.

In 2025, Chron.com reported the company was working to construct an estimated $96 million facility to breed genetically engineered animals. Head of investor relations at United Therapeutics Dewey Steadman told the Houston Business Journal in 2025 that the pigs’ DNA will be edited. In November 2024, a 53-year-old woman in Alabama received a transplanted kidney from UKidney that had 10 gene edits. She had the transplant removed in April 2025, after her body rejected it.

The Dr. Bartley P. Griffith and Dr. Robert A. Montgomery Xenograft Production Facility requires a “strictly controlled, biosecure barrier environment, including air filtration, filtered water, filtered feed supplies, and state-of-the-art decontamination entryways,” according to the company. Being pathogen-free means it includes calibrated air and water conduits to support the transplantability of xenograft products and to prevent contamination. For energy considerations, the building also features solar arrays.

“With our third xenograft production facility now open and clinical trials underway, United Therapeutics is moving closer to its goal of providing transplantable organs to the people who need them,” Martine Rothblatt, chairperson and CEO of United Therapeutics, said in a news release. “It is fitting that this facility is named for Dr. Griffith and Dr. Montgomery, whose first-in-human surgeries turned xenotransplantation from a theoretical possibility into a clinical reality.”

The facility, which wrapped construction in August, is located at 11848 Common Dock Dr. in Generation Park, which will house manufacturing sites for pharmaceutical heavyweights Bristol Myers Squibb and Eli Lilly. Last fall, Eli Lilly tapped Generation Park for its $6.5 billion manufacturing plant, and Bristol Myers Squibb made a $2.3 billion investment in August to bring its state-of-the-art site to the master-planned commercial district.

Elon Musk's SpaceX reports profit as AI and satellite businesses booms

Booming Business

SpaceX reported a bigger quarterly profit than expected on Tuesday, October 20, as its satellite communications and artificial intelligence businesses boomed.

The company, run by Elon Musk, posted a profit for the three months through September 2026 of $4.4 billion, or 35 cents per share, reversing a year-ago loss and easily topping Wall Street's expectations. Revenue soared to $14.6 billion, up 161%.

On a conference call with analysts, Musk suggested a merger with his electric car company Tesla might be in the works, something that has been rumored for months. He said both companies formed “special committees” of independent directors to discuss the issue, though he played down the chances of an imminent deal.

“Some people out there assume that a SpaceX and Tesla merger is a certainty,” he said. “I think that would be overstating it.”

The AI business became SpaceX's largest by revenue in the third quarter, although the Starlink satellite service remains the biggest profit generator.

“They beat across all metrics and the Starlink business looks to be accelerating,” said Dan Ives, an analyst at Yorkville Ives. “This is just what (Wall) Street wanted.”

The stock rose 7.5% in after-hours trading.

Musk also told analysts that for next month's launch of its Starship rocket, SpaceX will attempt to grab both the booster and ship with mechanical arms upon return to base, a key step toward demonstrating it can reuse the massive spacecraft.

“The only way that we can extend consciousness beyond Earth on a sustained basis is with a fully reusable orbital launch vehicle,” Musk said, calling the attempt, if successful, “a massive technology milestone.”

SpaceX hopes to get Starship on a regular launch pattern in preparation for NASA's upcoming lunar missions.

The company already has huge contracts with the federal government, and House Democrats have called for investigations into those contracts and Musk’s work with the Department of Government Efficiency. Musk has spent $276 million since July in support of Republican candidates.

In a filing for its initial public offering in June, SpaceX warned that a change in control of Congress could have a “material and adverse impact on our growth and competitive position.”

Musk recently drew criticism from politicians in Washington after speeds for a military version of SpaceX's satellite communications service were slowed for Ukraine following President Donald Trump's deal to get more diesel oil from Russia amid a push to end the war. The Wall Street Journal reported Tuesday that it was Musk who ordered the slowdown, impeding Ukraine’s use of drones along the front. SpaceX did not immediately respond to an Associated Press request for comment on the Journal story.

Both Trump and Musk have denied responsibility for the slowdown.

As midterm elections near, Musk on Monday promised to give one share of SpaceX to “every kid in America” next year, though he provided no details on how the distribution would be carried out. With communities nationwide protesting the construction of large data centers and concerns about AI safety, AI companies are trying to build goodwill. Anthropic pledged to commit 5% of its shares to a new “public benefit” fund.

SpaceX shares have been under pressure over concerns that the company was spending too much on major projects to compete with rivals such as Anthropic. The company said capital expenditures totaled $19.6 billion last quarter, nearly triple the figure from a year earlier, and it forecast spending would grow to $35 billion to $40 billion in the current quarter.

Shares of SpaceX closed Tuesday at $147.79, down from a peak near $201 after its IPO, which made Musk the world’s first trillionaire at the time. But the share prices for SpaceX and Tesla have since dropped, reducing his net worth to $925 billion, according to Forbes magazine.

Tesla reports third-quarter financial results Wednesday. Last week, Tesla unveiled a new Roadster sports car that in some versions may include thrusters allowing it to briefly fly using SpaceX technology — though experts say anything usable for drivers is a long shot.